Union Bancaire Privee, UBP SA »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Union Bancaire Privee, UBP SA

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Union Bancaire Privee, UBP SA from 13F filings

Historical chart of Union Bancaire Privee, UBP SA investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Union Bancaire Privee, UBP SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Union Bancaire Privee, UBP SA

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 4.4M 1.20
2025-06-30 $4.4M 4.5M 0.98
2025-03-31 $5.5M 4.5M 1.22

More positions owned by Union Bancaire Privee, UBP SA

Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Apple (AAPL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Oracle Corporation (ORCL)
Owl Rock Capital Corporation (OBDC)
Cisco Systems (CSCO)
Hercules Technology Growth Capital (HTGC)

View all positions for Union Bancaire Privee, UBP SA

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1